Sign in
CompletedNo phase

Predicting the Outcome of ADHD in White Matter Injure Neonates With Multi-modality MRI

Key facts

Who runs it
First Affiliated Hospital Xi'an Jiaotong University
Where
China9 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
348 people enrolled
Started
29 Jan 2023
Ended
30 May 2025
Type of study
Observational, 2 groups
Record updated
23 September 2026

Who can take part

Age
1 day and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Neonates diagnosed with white matter injury (WMI) or neonates without obvious abnormalities on routine MRI examination from the multicenter database
  • Brain MRI examination performed within 28 days after birth, with gestational age ≤42 weeks at examination
  • Complete MRI data available, including T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), and diffusion tensor imaging (DTI)
  • Complete maternal and pregnancy history information, neonatal demographic characteristics, and clinical information available

Who cannot take part

  • Congenital nervous system developmental malformations or suspected genetic or metabolic diseases
  • Obvious MRI artifacts affecting image evaluation
  • Inability to complete follow-up neurobehavioral assessments

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this bidirectional observational cohort study is to investigate the longitudinal relationship between neonatal white matter injury (WMI) and the subsequent development of attention-deficit/hyperactivity disorder (ADHD), and to identify early MRI-based markers associated with ADHD-related outcomes. The study includes both retrospective and prospective cohorts to dynamically evaluate the evolution of brain injury, brain development, and behavioral outcomes from infancy to childhood.

Read full original descriptionShow less

The main questions it aims to answer are:

Are neonatal WMI characteristics associated with the subsequent development of ADHD? Which MRI-derived features, including semi-quantitative WMI assessment, microstructural alterations, and structural disconnection patterns, are associated with ADHD-related outcomes?

Participants with neonatal WMI will undergo longitudinal clinical, neurodevelopmental, and behavioral follow-up. Researchers will analyze clinical information and MRI findings to characterize WMI evolution and identify imaging markers associated with ADHD risk. Participants will:

undergo brain MRI examinations according to clinical protocols; receive standardized neurodevelopmental and behavioral assessments during follow-up; have MRI-derived measures, including semi-quantitative WMI scores, white matter microstructural features, and structural disconnection measures, analyzed to investigate their associations with ADHD-related outcomes.

The 2 groups in the trial

  • White matter injure group

    Neonates presented with punctate, linear, or clustered white matter lesions at the center of the semiovale and lateral ventricles, with TIWI hyper-intensive s and with or without T2WI hypointensity.

  • Control group

    No abnormal signals are found on both conventional and diffusion images. SWI and ASL are also considered when necessary.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Multi-center Longitudinal Clinical Study on the Evolution of Neonatal White Matter Injure to ADHD Based on Multi-modality MRI
Record updated
23 September 2026